Ghimire Anukul, Platnich Jaye, Chauhan Utkarsh
Department of Medicine, University of Alberta, Edmonton, AB T6G 2G3, Canada.
Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R7, Canada.
Infect Dis Rep. 2022 Jun 2;14(3):413-419. doi: 10.3390/idr14030044.
Warm autoimmune hemolytic anemia (AIHA) is a rare complication of COVID-19 infection. We report a case of warm AIHA in a patient with COVID-19 pneumonia treated with methylprednisolone and several red blood cell transfusions. Despite treatment of the warm AIHA, the patient's reticulocyte count remained low, and his biochemical markers were suggestive of pure red cell aplasia, which was later attributed to a concurrent parvovirus B19 infection. This case highlights an unusual situation of two separate hematological processes caused by two separate and simultaneous viral infections.
温抗体型自身免疫性溶血性贫血(AIHA)是新型冠状病毒肺炎(COVID-19)感染的一种罕见并发症。我们报告一例COVID-19肺炎患者发生温抗体型AIHA的病例,该患者接受了甲泼尼龙治疗并多次输注红细胞。尽管对温抗体型AIHA进行了治疗,但患者的网织红细胞计数仍然很低,其生化指标提示纯红细胞再生障碍,后来发现这是由同时感染的细小病毒B19所致。该病例凸显了由两种独立且同时发生的病毒感染引起的两种不同血液学过程的罕见情况。